Shenyang Sunshine Pharmaceutical Co., Ltd.

This early-stage study tests a new drug, SPGL008, in 96 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. Participants will receive the drug either through…

This early-stage study tests a new drug, SSGJ-709, in 15 adults with advanced solid tumors that have spread. The main goals are to check the drug's safety and how the body processes it. Researchers will also look for signs that the drug shrinks tumors.

This study tests a new drug called SSGJ-706, alone or with other treatments, for people with advanced non-small cell lung cancer (NSCLC) that has not been treated before. About 240 adults will take part to see if the drug shrinks tumors and to check for side effects. The goal is …

This early-stage study tests whether a new injection called SSS55 is safe and tolerable in healthy adults aged 18 to 45. 26 participants will receive either the drug or a placebo. The goal is to check for side effects and how the body processes the drug, not to treat any disease.